Jerry Wan
Net worth: 209 895 $ as of 2026-07-30
Net worth: 209 895 $ as of 2026-07-30
Jerry Wan is currently Vice President-Finance at Achieve Life Sciences, Inc. since 2025, with employment at the firm starting in 2017.
Formerly, Mr. Wan was Director-Accounting Operations at OncoGenex Pharmaceuticals, Inc. from 2014 to 2017 and Manager-Management Reporting at Gateway Casinos & Entertainment Ltd. from 2010 to 2011.
Education includes an undergraduate degree from the University of British Columbia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-27 | 32,694 ( 0.03% ) | 209 895 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Corporate Officer/Principal | 2025-01-31 |
| Companies | Position | End |
|---|---|---|
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Director of Finance/CFO | 2014-06-30 |
Gateway Casinos & Entertainment Ltd.
Gateway Casinos & Entertainment Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates and manages casinos & hotels | Corporate Officer/Principal | 2010-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Gateway Casinos & Entertainment Ltd.
Gateway Casinos & Entertainment Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates and manages casinos & hotels | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Select your edition
All financial news and data tailored to specific country editions